Koronis Pharmaceuticals Secures $1,000,000 New Funding Round

  • Feed Type
  • Date
    1/13/2012
  • Company Name
    Koronis Pharmaceuticals
  • Mailing Address
    720 3rd Ave. Seattle, WA 98104
  • Company Description
    Koronis Pharmaceuticals, Inc. is a privately held biotechnology company
    developing anti-viral therapeutics based on Viral Decay Acceleration(TM).
    In addition to the Company’s lead product candidate, KP-1461 for AIDS/HIV,
    the Company has programs directed toward the development of therapeutics
    for hepatitis C and RSV.
  • Website
    http://www.koronispharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.